Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
US |
|
A
|
Advtech Ltd
JSE:ADH
|
ZA |
|
Olaplex Holdings Inc
NASDAQ:OLPX
|
US |
|
Sensient Technologies Corp
NYSE:SXT
|
US |
|
Unicharm Corp
TSE:8113
|
JP |
|
A
|
AXA SA
XMUN:AXA
|
FR |
|
L
|
Lindbergh SpA
MIL:LDB
|
IT |
|
G
|
Gentili Mosconi SpA
MIL:GM
|
IT |
|
M
|
Mit SIM SpA
MIL:MTS
|
IT |
|
Mister Car Wash Inc
NYSE:MCW
|
US |
|
M
|
Mercedes Benz Group AG
XHAM:MBG
|
DE |
|
Elanco Animal Health Inc
NYSE:ELAN
|
US |
|
I
|
Informa PLC
OTC:IFJPY
|
UK |
|
Annaly Capital Management Inc
NYSE:NLY
|
US |
|
T
|
Tencent Holdings Ltd
XHAM:NNND
|
CN |
|
Citigroup Inc
NYSE:C
|
US |
|
Konami Holdings Corp
TSE:9766
|
JP |
|
S
|
SK Growth Opportunities Corp
NASDAQ:SKGR
|
US |
|
I
|
Ispire Technology Inc
NASDAQ:ISPR
|
US |
|
CorMedix Inc
NASDAQ:CRMD
|
US |
|
Vita Coco Company Inc
NASDAQ:COCO
|
US |
|
Ulta Beauty Inc
NASDAQ:ULTA
|
US |
|
D
|
Diamondrock Hospitality Co
F:HBO
|
US |
|
ArcelorMittal SA
AEX:MT
|
LU |
Wall St Price Targets
BMRN Price Targets Summary
Biomarin Pharmaceutical Inc
According to Wall Street analysts, the average 1-year price target for BMRN is 92.68 USD with a low forecast of 55.55 USD and a high forecast of 126 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BMRN's stock price target?
Price Target
92.68
USD
According to Wall Street analysts, the average 1-year price target for BMRN is 92.68 USD with a low forecast of 55.55 USD and a high forecast of 126 USD.
What is the Revenue forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 9%.
What is the Operating Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
14%
The compound annual growth rate for Operating Income over the next 8 years is 14%.
What is the Net Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
27%
The compound annual growth rate for Net Income over the next 8 years is 27%.
